Cargando…

EPSILoN: A Prognostic Score for Immunotherapy in Advanced Non-Small-Cell Lung Cancer: A Validation Cohort

Background: Beyond programmed death ligand 1 (PD-L1), no other biomarkers for immunotherapy are used in daily practice. We previously created EPSILoN (Eastern Cooperative Oncology Group performance status (ECOG PS), smoking, liver metastases, lactate dehydrogenase (LDH), neutrophil-to-lymphocyte rat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Prelaj, Arsela, Ferrara, Roberto, Rebuzzi, Sara Elena, Proto, Claudia, Signorelli, Diego, Galli, Giulia, De Toma, Alessandro, Randon, Giovanni, Pagani, Filippo, Viscardi, Giuseppe, Brambilla, Marta, Trevisan, Benedetta, Ganzinelli, Monica, Martinetti, Antonia, Gallucci, Rosaria, Di Mauro, Rosa Maria, Molino, Giuliano, Zilembo, Nicoletta, Torri, Valter, de Braud, Filippo Maria, Garassino, Marina Chiara, Lo Russo, Giuseppe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966664/ https://www.ncbi.nlm.nih.gov/pubmed/31817541 http://dx.doi.org/10.3390/cancers11121954

Ejemplares similares

Integrating clinical and biological prognostic biomarkers in patients with advanced NSCLC treated with immunotherapy: the DEMo score system
por: Prelaj, Arsela, et al.
Publicado: (2020)

Circulating CD81-expressing extracellular vesicles as biomarkers of response for immune-checkpoint inhibitors in advanced NSCLC
por: Signorelli, Diego, et al.
Publicado: (2022)

Concomitant EML4-ALK rearrangement and EGFR mutation in non-small cell lung cancer patients: a literature review of 100 cases
por: Lo Russo, Giuseppe, et al.
Publicado: (2017)

Novel patterns of progression upon immunotherapy in other thoracic malignancies and uncommon populations
por: Ferrara, Roberto, et al.
Publicado: (2021)

Modulation of peripheral blood immune cells by early use of steroids and its association with clinical outcomes in patients with metastatic non-small cell lung cancer treated with immune checkpoint inhibitors
por: Fucà, Giovanni, et al.
Publicado: (2019)

SMO mutations confer poor prognosis in malignant pleural mesothelioma
por: Signorelli, Diego, et al.
Publicado: (2020)

Is There an Interplay between Immune Checkpoint Inhibitors, Thromboprophylactic Treatments and Thromboembolic Events? Mechanisms and Impact in Non-Small Cell Lung Cancer Patients
por: Nichetti, Federico, et al.
Publicado: (2019)

Machine Learning Using Real-World and Translational Data to Improve Treatment Selection for NSCLC Patients Treated with Immunotherapy
por: Prelaj, Arsela, et al.
Publicado: (2022)

Evaluation of Drug—Drug Interactions in EGFR-Mutated Non-Small-Cell Lung Cancer Patients during Treatment with Tyrosine-Kinase Inhibitors
por: Occhipinti, Mario, et al.
Publicado: (2021)

Beyond First-Line Immunotherapy: Potential Therapeutic Strategies Based on Different Pattern Progressions: Oligo and Systemic Progression
por: Prelaj, Arsela, et al.
Publicado: (2021)

Real-world data to build explainable trustworthy artificial intelligence models for prediction of immunotherapy efficacy in NSCLC patients
por: Prelaj, Arsela, et al.
Publicado: (2023)

PEOPLE (NTC03447678), a phase II trial to test pembrolizumab as first-line treatment in patients with advanced NSCLC with PD-L1 <50%: a multiomics analysis
por: Lo Russo, Giuseppe, et al.
Publicado: (2023)

Case Report: Exceptional Response to Poziotinib in Patient with Metastatic Non-Small Cell Lung Cancer With EGFR Exon 20 Insertion Mutation
por: Prelaj, Arsela, et al.
Publicado: (2022)

PEOPLE (NCT03447678), a first-line phase II pembrolizumab trial, in negative and low PD-L1 advanced NSCLC: clinical outcomes and association with circulating immune biomarkers
por: Lo Russo, G., et al.
Publicado: (2022)

LKB1 mutations are not associated with the efficacy of first-line and second-line chemotherapy in patients with advanced non-small-cell lung cancer (NSCLC): a post hoc analysis of the TAILOR trial
por: Vernieri, Claudio, et al.
Publicado: (2020)

The Evaluation of Response to Immunotherapy in Metastatic Renal Cell Carcinoma: Open Challenges in the Clinical Practice
por: Raimondi, Alessandra, et al.
Publicado: (2019)

The Landscape of Actionable Gene Fusions in Colorectal Cancer
por: Pagani, Filippo, et al.
Publicado: (2019)

Treatment patterns among patients with malignant pleural mesothelioma: An Italian, population‐based nationwide study
por: Trama, Annalisa, et al.
Publicado: (2020)

MicroRNAs for the Diagnosis and Management of Malignant Pleural Mesothelioma: A Literature Review
por: Lo Russo, Giuseppe, et al.
Publicado: (2018)

Beyond LKB1 Mutations in Non-Small Cell Lung Cancer: Defining LKB1less Phenotype to Optimize Patient Selection and Treatment
por: Borzi, Cristina, et al.
Publicado: (2020)

Measurement of $\epsilon'/\epsilon$
por: Lubrano, Pasquale
Publicado: (1999)

Gluino penguins and epsilon'/epsilon
por: Gérard, J M, et al.
Publicado: (1984)

New $\epsilon{'}/\epsilon$ results
por: Biino, C
Publicado: (2001)

$\epsilon'$/$\epsilon$: three years later
por: Ciuchini, Marco
Publicado: (1997)

The NA31 $\epsilon'\epsilon$ measurement
por: Nappi, A, et al.
Publicado: (1990)

Review of epsilon'/epsilon measurements and their problems
por: Wahl, H
Publicado: (1986)

$\epsilon '/\epsilon$ by the NA48 experiment
por: Sozzi, M
Publicado: (2001)

Measurement of $\epsilon '/ \epsilon$ with NA48
por: Unal, G
Publicado: (2001)

The precise determination of Re(epsilon'/epsilon)
por: Cirilli, M
Publicado: (2001)

Status of $\epsilon'$ /$\epsilon$ in the Standard Model
por: Gisbert, Hector
Publicado: (2019)

TERAVOLT: Thoracic Cancers International COVID-19 Collaboration
por: Whisenant, Jennifer G., et al.
Publicado: (2020)

Neoadjuvant Chemotherapy in Neuroendocrine Bladder Cancer: A Case Report
por: Prelaj, Arsela, et al.
Publicado: (2016)

Randomised Phase II Trial (NCT00637975) Evaluating Activity and Toxicity of Two Different Escalating Strategies for Pregabalin and Oxycodone Combination Therapy for Neuropathic Pain in Cancer Patients
por: Garassino, Marina Chiara, et al.
Publicado: (2013)

The final measurement of $\epsilon'/\epsilon$ by NA48
por: Unal, G.
Publicado: (2002)

The NA48 experiment for the measurement of $\epsilon^{'}/\epsilon$
por: Augustin, I
Publicado: (1997)

A Brief History of $Re(\epsilon'/\epsilon)$
por: Iconomidou-Fayard, L
Publicado: (2000)

New results on epsilon'/epsilon by NA48
por: Lenti, M
Publicado: (2001)

Circulating biomarkers in malignant pleural mesothelioma
por: Viscardi, Giuseppe, et al.
Publicado: (2020)

The quest for the direct CP violation parameter, epsilon'/epsilon
por: Soni, Amarjit
Publicado: (2015)

Measurement of $\epsilon'/\epsilon$ from the NA48 experiment
por: Ocariz, Jose
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_pqca2tfpjjct6c7rbg1g4l0sks